The presence of type 2 diabetes is considered a risk factor for the development of chronic kidney disease (CKD). Simple screening measures based on blood and urine samples can detect CKD at an early stage. This is becoming increasingly important, as the progression of kidney failure – especially in the early stages – can now be effectively delayed with medication.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
- CARDIOVASC
- Nephrologie-Special
Related Topics
You May Also Like
- Study report
Sphingolipid profile in early-stage primary biliary cholangitis
- Angiosarcoma of the heart
A diagnostic and therapeutic “black box”
- Ataxias
Friedreich’s ataxia: when the energy metabolism attacks the nervous system
- Risk of osteoporosis in autoimmune liver diseases
Always determine bone density in PBC, PSC and AIH
- Case report: Complication after type 2 diabetes
Topical corticosteroids lead to ketoacidosis
- NSCLC
Bispecific antibodies for rare EGFR mutations
- Type 2 diabetes - glycemic control and prevention of secondary diseases
Utilizing pleiotropic cardio- and nephroprotective effects of SGLT-2-i and GLP-1-RA
- Subsyndromal anxiety disorders: Family doctor as first point of contact